Correlation Between Spyre Therapeutics and Moog
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Moog at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Moog into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Moog Inc A, you can compare the effects of market volatilities on Spyre Therapeutics and Moog and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Moog. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Moog.
Diversification Opportunities for Spyre Therapeutics and Moog
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Spyre and Moog is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Moog Inc A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moog Inc A and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Moog. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moog Inc A has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Moog go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Moog
If you would invest (100.00) in Moog Inc A on October 10, 2024 and sell it today you would earn a total of 100.00 from holding Moog Inc A or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Spyre Therapeutics vs. Moog Inc A
Performance |
Timeline |
Spyre Therapeutics |
Moog Inc A |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Spyre Therapeutics and Moog Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spyre Therapeutics and Moog
The main advantage of trading using opposite Spyre Therapeutics and Moog positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Moog can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moog will offset losses from the drop in Moog's long position.Spyre Therapeutics vs. Weibo Corp | Spyre Therapeutics vs. NETGEAR | Spyre Therapeutics vs. Borr Drilling | Spyre Therapeutics vs. Reservoir Media |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |